SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-22-003663
Filing Date
2022-05-03
Accepted
2022-05-03 16:14:22
Documents
2
Period of Report
2022-05-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4226
2 POWER OF ATTORNEY donovan-poa.txt EX-24 2007
  Complete submission text file 0001562180-22-003663.txt   7618
Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ. BLDG. 1400E SUITE B14202 CAMBRIDGE MA 02139
Business Address
Donovan Joanne M. (Reporting) CIK: 0001644087 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40236 | Film No.: 22887011

Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address 3415 COLORADO AVE. BOULDER CO 80303 303-735-8373
Edgewise Therapeutics, Inc. (Issuer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations